IL-37: A new player in the chronic rhinosinusitis arena

J Allergy Clin Immunol. 2020 Jan;145(1):105-107. doi: 10.1016/j.jaci.2019.10.018. Epub 2019 Oct 28.

Authors

Nikita Markov¹, Hans-Uwe Simon²

Affiliations

¹ Institute of Pharmacology, University of Bern, Bern, Switzerland.
² Institute of Pharmacology, University of Bern, Bern, Switzerland; Department of Clinical Immunology and Allergology, Sechenov University, Moscow, Russia. Electronic address: hus@pki.unibe.ch.

PMID: 31672607
DOI: 10.1016/j.jaci.2019.10.018

No abstract available

Keywords: Antiviral response; IL-37; Mex3B; chronic rhinosinusitis; cytokines; epithelial cells; inflammation.

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Epithelial Cells
Humans
Nasal Polyps*
RNA-Binding Proteins
Rhinitis*
Sinusitis*
Toll-Like Receptor 3

Substances

MEX3B protein, human
RNA-Binding Proteins
Toll-Like Receptor 3